nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—ABCB1—adrenal gland cancer	0.966	1	CbGaD
Mebendazole—Albendazole—ABCB1—adrenal gland cancer	0.00301	0.312	CrCbGaD
Mebendazole—CYP3A4—urine—adrenal gland cancer	0.00272	0.115	CbGeAlD
Mebendazole—TUBA1A—adrenal cortex—adrenal gland cancer	0.00263	0.111	CbGeAlD
Mebendazole—Ketorolac—PTGS2—adrenal gland cancer	0.00228	0.237	CrCbGaD
Mebendazole—TUBA1A—gonad—adrenal gland cancer	0.00218	0.0923	CbGeAlD
Mebendazole—TUBA1A—cardiac atrium—adrenal gland cancer	0.00218	0.0922	CbGeAlD
Mebendazole—TUBA1A—pituitary gland—adrenal gland cancer	0.00213	0.0901	CbGeAlD
Mebendazole—TUBA1A—adrenal gland—adrenal gland cancer	0.0019	0.0805	CbGeAlD
Mebendazole—Tiaprofenic acid—PTGS2—adrenal gland cancer	0.00186	0.193	CrCbGaD
Mebendazole—Nepafenac—PTGS2—adrenal gland cancer	0.00177	0.184	CrCbGaD
Mebendazole—TUBB4B—adrenal cortex—adrenal gland cancer	0.00175	0.0743	CbGeAlD
Mebendazole—TUBB4B—gonad—adrenal gland cancer	0.00145	0.0615	CbGeAlD
Mebendazole—TUBB4B—cardiac atrium—adrenal gland cancer	0.00145	0.0615	CbGeAlD
Mebendazole—TUBB4B—pituitary gland—adrenal gland cancer	0.00142	0.06	CbGeAlD
Mebendazole—TUBB4B—adrenal gland—adrenal gland cancer	0.00127	0.0536	CbGeAlD
Mebendazole—CYP1A1—cardiac atrium—adrenal gland cancer	0.000812	0.0344	CbGeAlD
Mebendazole—Ketoprofen—PTGS2—adrenal gland cancer	0.000716	0.0744	CrCbGaD
Mebendazole—ABCB1—adrenal cortex—adrenal gland cancer	0.00051	0.0216	CbGeAlD
Mebendazole—ABCB1—gonad—adrenal gland cancer	0.000422	0.0179	CbGeAlD
Mebendazole—ABCB1—pituitary gland—adrenal gland cancer	0.000412	0.0175	CbGeAlD
Mebendazole—ABCB1—adrenal gland—adrenal gland cancer	0.000368	0.0156	CbGeAlD
Mebendazole—TUBA1A—Loss of Nlp from mitotic centrosomes—PRKACA—adrenal gland cancer	6.21e-05	0.0625	CbGpPWpGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—CDC42—adrenal gland cancer	5.72e-05	0.0576	CbGpPWpGaD
Mebendazole—TUBA1A—Centrosome maturation—PRKACA—adrenal gland cancer	5.5e-05	0.0554	CbGpPWpGaD
Mebendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—PRKACA—adrenal gland cancer	5.05e-05	0.0508	CbGpPWpGaD
Mebendazole—TUBA1A—G2/M Transition—PRKACA—adrenal gland cancer	3.79e-05	0.0382	CbGpPWpGaD
Mebendazole—TUBB4B—Loss of Nlp from mitotic centrosomes—PRKACA—adrenal gland cancer	3.75e-05	0.0377	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—PRKACA—adrenal gland cancer	3.74e-05	0.0376	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—CDC42—adrenal gland cancer	3.45e-05	0.0348	CbGpPWpGaD
Mebendazole—TUBB4B—Centrosome maturation—PRKACA—adrenal gland cancer	3.32e-05	0.0334	CbGpPWpGaD
Mebendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—PRKACA—adrenal gland cancer	3.05e-05	0.0307	CbGpPWpGaD
Mebendazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	2.83e-05	0.0285	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—RB1—adrenal gland cancer	2.67e-05	0.0269	CbGpPWpGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—CTNNB1—adrenal gland cancer	2.63e-05	0.0264	CbGpPWpGaD
Mebendazole—TUBB4B—G2/M Transition—PRKACA—adrenal gland cancer	2.29e-05	0.023	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—PRKACA—adrenal gland cancer	2.26e-05	0.0227	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—adrenal gland cancer	1.59e-05	0.016	CbGpPWpGaD
Mebendazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	1.55e-05	0.0156	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—REN—adrenal gland cancer	1.47e-05	0.0148	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	1.37e-05	0.0138	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	1.36e-05	0.0137	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TOP2A—adrenal gland cancer	1.22e-05	0.0123	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—MED12—adrenal gland cancer	1.22e-05	0.0123	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	1.21e-05	0.0121	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	1.19e-05	0.012	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—PRKACA—adrenal gland cancer	1.08e-05	0.0109	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	9.46e-06	0.00953	CbGpPWpGaD
Mebendazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	9.35e-06	0.00942	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	9.04e-06	0.0091	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	8.91e-06	0.00897	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—REN—adrenal gland cancer	8.89e-06	0.00895	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	8.4e-06	0.00846	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	8.27e-06	0.00833	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	8.22e-06	0.00828	CbGpPWpGaD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.88e-06	0.00794	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	7.78e-06	0.00783	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TOP2A—adrenal gland cancer	7.39e-06	0.00745	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—IGF2—adrenal gland cancer	7.35e-06	0.0074	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TERT—adrenal gland cancer	7.34e-06	0.00739	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	7.28e-06	0.00733	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	7.28e-06	0.00733	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	7.28e-06	0.00733	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—PRKACA—adrenal gland cancer	6.51e-06	0.00656	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.39e-06	0.00644	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—RB1—adrenal gland cancer	6.38e-06	0.00643	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	5.97e-06	0.00601	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—RB1—adrenal gland cancer	5.71e-06	0.00575	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	5.61e-06	0.00565	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	5.51e-06	0.00555	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	5.51e-06	0.00555	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	5.19e-06	0.00523	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2A—adrenal gland cancer	5.02e-06	0.00505	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—POMC—adrenal gland cancer	4.9e-06	0.00494	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.84e-06	0.00487	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	4.75e-06	0.00478	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—IGF2—adrenal gland cancer	4.44e-06	0.00447	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TERT—adrenal gland cancer	4.43e-06	0.00446	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	3.88e-06	0.00391	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RB1—adrenal gland cancer	3.86e-06	0.00388	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CTNNB1—adrenal gland cancer	3.5e-06	0.00352	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RB1—adrenal gland cancer	3.45e-06	0.00347	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—POMC—adrenal gland cancer	3.4e-06	0.00342	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	3.39e-06	0.00341	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.27e-06	0.0033	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	3.15e-06	0.00317	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SDHB—adrenal gland cancer	3.04e-06	0.00306	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2A—adrenal gland cancer	3.03e-06	0.00305	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—POMC—adrenal gland cancer	2.96e-06	0.00298	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—adrenal gland cancer	2.79e-06	0.00281	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	2.71e-06	0.00272	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SDHB—adrenal gland cancer	2.42e-06	0.00244	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.39e-06	0.00241	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CTNNB1—adrenal gland cancer	2.11e-06	0.00213	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.99e-06	0.002	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SDHD—adrenal gland cancer	1.96e-06	0.00197	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—RRM1—adrenal gland cancer	1.96e-06	0.00197	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.81e-06	0.00183	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.78e-06	0.00179	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—adrenal gland cancer	1.69e-06	0.0017	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	1.67e-06	0.00168	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.56e-06	0.00157	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.56e-06	0.00157	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SDHB—adrenal gland cancer	1.49e-06	0.0015	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.47e-06	0.00148	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MED12—adrenal gland cancer	1.46e-06	0.00147	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.41e-06	0.00142	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.3e-06	0.00131	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.18e-06	0.00119	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MED12—adrenal gland cancer	1.16e-06	0.00117	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	1.06e-06	0.00107	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.04e-06	0.00105	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—RRM1—adrenal gland cancer	9.63e-07	0.000969	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SDHD—adrenal gland cancer	9.63e-07	0.000969	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GNAS—adrenal gland cancer	8.62e-07	0.000868	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PRKACA—adrenal gland cancer	8.5e-07	0.000856	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	8.46e-07	0.000852	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MED12—adrenal gland cancer	7.18e-07	0.000723	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GNAS—adrenal gland cancer	6.89e-07	0.000694	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—POMC—adrenal gland cancer	5.81e-07	0.000585	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	5.24e-07	0.000527	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—POMC—adrenal gland cancer	4.64e-07	0.000467	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	4.63e-07	0.000466	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GNAS—adrenal gland cancer	4.24e-07	0.000427	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	4.16e-07	0.000419	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—adrenal gland cancer	3.7e-07	0.000373	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—POMC—adrenal gland cancer	2.86e-07	0.000288	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.28e-07	0.00023	CbGpPWpGaD
